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Abstract. 
 
AP-1 and AP-2 adaptors are recruited onto 
the TGN and plasma membrane, respectively. GTP
 
g
 
S 
stimulates the recruitment of AP-1 onto the TGN but 
causes AP-2 to bind to an endosomal compartment 
(Seaman, M.N.J., C.L. Ball, and M.S. Robinson. 1993. 
 
J. 
Cell Biol.
 
 123:1093–1105). We have used subcellular 
fractionation followed by Western blotting, as well as 
immunofluorescence and immunogold electron micros-
copy, to investigate both the recruitment of AP-2 adap-
tors onto the plasma membrane and their targeting to 
endosomes, and we have also examined the recruitment 
of AP-1 under the same conditions. Two lines of evi-
dence indicate that the GTP
 
g
 
S-induced targeting of 
AP-2 to endosomes is mediated by ADP-ribosylation 
factor-1 (ARF1). First, GTP
 
g
 
S loses its effect when 
added to ARF-depleted cytosol, but this effect is re-
stored by the addition of recombinant myristoylated 
ARF1. Second, adding constitutively active Q71L 
ARF1 to the cytosol has the same effect as adding 
GTP
 
g
 
S. The endosomal membranes that recruit AP-2 
adaptors have little ARF1 or any of the other ARFs as-
sociated with them, suggesting that ARF may be acting 
catalytically. The ARFs have been shown to activate 
phospholipase D (PLD), and we find that addition of 
exogenous PLD has the same effect as GTP
 
g
 
S or Q71L 
ARF1. Neomycin, which inhibits endogenous PLD by 
binding to its cofactor phosphatidylinositol 4,5-bisphos-
phate, prevents the recruitment of AP-2 not only onto 
endosomes but also onto the plasma membrane, sug-
gesting that both events are mediated by PLD. Surpris-
ingly, however, neither PLD nor neomycin has any ef-
fect on the recruitment of AP-1 adaptors onto the 
TGN, even though AP-1 recruitment is ARF mediated. 
These results indicate that different mechanisms are 
used for the recruitment of AP-1 and AP-2.
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1. 
 
Abbreviations used in this paper
 
: AFR, ADP-ribosylation factor; BFA,
brefeldin A; NRK, normal rat kidney; PA, phosphatidic acid; PIP
 
2
 
, phos-
phatidylcholine 4,5-bisphosphate; PLD, phospholipase D.
 
P
 
roteins 
 
are transported from one membrane com-
partment of the cell to another by means of carrier
vesicles. The first step in the formation of these ves-
icles is the recruitment of cytosolic proteins onto a “do-
nor” membrane compartment, where they assemble into a
coat. This coat may serve two purposes: to deform the
membrane into a budding vesicle and to select the vesicle
cargo by interacting with the cytoplasmic domains of some
of the proteins in the donor membrane (Schekman and
Orci, 1996).
The process of coat recruitment is still not well under-
stood, although it is thought that there are specific docking
sites on the membrane for coat proteins. In addition, in
most cases a small GTP-binding protein has been shown to
be involved in coat recruitment, somehow priming the
membrane for the subsequent binding of coat proteins.
Thus, the coatomer or COPI coat, which is recruited onto
the membranes of the Golgi stack and intermediate com-
partment, requires ADP-ribosylation factor (ARF)
 
1
 
 for its
membrane association, and studies making use of purified
components have implicated the most abundant of the
ARF isoforms, ARF1, in this event (Donaldson et al.,
1992; Palmer et al., 1993). Similar studies have shown that
ARF1 also allows AP-1 adaptors to be recruited onto the
TGN membrane, after which clathrin binds to the adap-
tors and the two components coassemble to form a clath-
rin-coated bud (Stamnes and Rothman, 1993; Traub et al.,
1993). Recently, an adaptor-related complex, called AP-3,
has been identified; AP-3 is also recruited onto the TGN,
but it is not associated with clathrin. Although studies
have not yet been carried out using purified components,
AP-3 recruitment is affected by reagents that act on ARF,
indicating that it too requires ARF (Simpson et al., 1996,
1997). In contrast, the COPII coat, which is associated
with the ER, requires another small GTP-binding protein,
Sar1p, to bind to the membrane (Barlowe et al., 1994).
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There is one other well-characterized type of coat in the
cell, which mediates the formation of endocytic-coated
vesicles at the plasma membrane and which consists of
clathrin and AP-2 adaptors. The subunits of the AP-2
adaptor complex are closely related to those of the AP-1
complex and more distantly related to those of the AP-3
complex. However, unlike AP-1 and AP-3, AP-2 recruit-
ment does not appear to be dependent on a conventional
ARF. Thus, the drug brefeldin A (BFA), which prevents
the nucleotide exchange of most ARFs, causes AP-1, AP-3,
and coatomer to redistribute to the cytoplasm when added
to living cells, while the distribution of AP-2 remains un-
changed (Donaldson et al., 1990; Robinson and Kreis,
1992; Simpson et al., 1997). Similarly, in an in vitro system,
BFA prevents the binding of AP-1, AP-3, and coatomer to
their target membranes, without affecting the binding of
AP-2 to the plasma membrane (Orci et al., 1991; Robinson
and Kreis, 1992; Seaman et al., 1993; Simpson et al., 1996).
Intriguingly, however, GTP
 
g
 
S, a poorly hydrolyzable ana-
logue of GTP, which stimulates the recruitment of other
coats onto their target membranes, does not stimulate the
binding of AP-2 adaptors to the plasma membrane but in-
stead causes them to become associated with a late endo-
somal compartment. This endosomal association can be
prevented by the addition of brefeldin A, indicating that it
is ARF dependent (Seaman et al., 1993). These observa-
tions suggest that docking sites for AP-2 adaptors exist
both on the plasma membrane and on the endosomal com-
partment, but that normally they are only active at the
plasma membrane, and that somehow GTP
 
g
 
S, presum-
ably acting via ARF, switches on endosomal docking sites
that normally are inactive. Whether recruitment of AP-2
adaptors onto the plasma membrane might also involve an
(unconventional) ARF or ARF-related protein is not known.
So far, five ARFs have been identified in humans (Price
et al., 1988; Bobak et al., 1989; Kahn et al., 1991; Tsuchiya
et al., 1991), in addition to the less closely related ARL
(ARF-like) family (Clark et al., 1993). ARF1 has been lo-
calized to the Golgi region in mammalian cells and has
been shown to associate with isolated Golgi membranes
(Stearns et al., 1990; Serafini et al., 1991). In other reports,
ARFs 1, 3, and 5 have been detected on crude Golgi/mi-
crosomal fractions (Tsai et al., 1992) and, together with
ARF4, have also been found on an endosome-enriched
fraction (Whitney et al., 1995), while ARF6 has been local-
ized to the plasma membrane (Cavenagh et al., 1996) and
endosomes (Peters et al., 1995). All of the ARFs have
been shown to be BFA sensitive, with the exception of
ARF6, the least related of the ARF family (Tsuchiya et
al., 1991). ARF6 also differs from the other ARFs in that it
appears to be constitutively membrane associated, instead
of cycling back and forth between membranes and cytosol
(Peters et al., 1995; Cavenagh et al., 1996).
The mechanism by which ARF promotes the recruit-
ment of cytosolic coat components onto the membrane is
still not understood. One possibility is that ARF may in-
teract directly with coat proteins, an idea supported by the
finding that ARF1 can bind to one of the coatomer subunits
(Zhao et al., 1997). A second possibility was proposed in a
study on AP-1 recruitment, in which it was suggested that
ARF might interact with the putative AP-1 docking site,
inducing a conformational change that would allow the
docking site to bind the adaptor complex (Traub et al.,
1993). A third possibility is that ARF may interact with
neither the coat proteins nor their docking sites, but exert
its effect through some other mechanism. ARF has been
reported to activate phospholipase D (PLD), which cata-
lyzes the hydrolysis of phosphatidylcholine to phospha-
tidic acid (Brown et al., 1993; Cockcroft et al., 1994), and a
recent study suggests that PLD may play a key role in
coatomer recruitment (Ktistakis et al., 1996).
Here we use an in vitro system to investigate both the
recruitment of AP-2 adaptors onto the plasma membrane
and their alternative targeting to the endosomal compart-
ment. As a comparison, we have also used our in vitro sys-
tem to study the recruitment of AP-1 adaptors. We have
raised a panel of monospecific anti-ARF antibodies and
have used these and recombinant ARF to investigate the
potential role of ARF(s) in adaptor recruitment. We find
that ARF1 can mediate not only the recruitment of AP-1
adaptors onto the TGN, but also the GTP
 
g
 
S-induced re-
cruitment of AP-2 adaptors onto endosomes. However,
ARF1 does not appear to be required for the recruitment
of AP-2 adaptors onto the plasma membrane. To investi-
gate the possibility that ARF may facilitate adaptor recruit-
ment through the activation of PLD, we have tested the ef-
fects of exogenous bacterial PLD and of neomycin, which
inhibits endogenous ARF-dependent PLD by binding to
its cofactor phosphatidylcholine 4,5-bisphosphate (PIP
 
2
 
).
We have found that neither reagent has any effect on AP-1
recruitment. However, exogenous PLD stimulates AP-2
recruitment onto the endosomal compartment, while neo-
mycin inhibits this event. Interestingly, neomycin also has
a strong effect on plasma membrane AP-2 binding, indi-
cating that the recruitment of AP-2 adaptors onto both
membranes may require PLD.
 
Materials and Methods
 
Production of Anti-ARF Antibodies
 
The full-length coding sequences for ARFs 1, 4, 5, and 6 were amplified by
PCR from human brain cDNA (CLONTECH Laboratories, Palo Alto,
CA) and ligated into pBluescript. DNA manipulations were carried out
essentially as described by Sambrook et al. (1989). Either full-length or
variable regions of the ARFs were then ligated into pGEX-3X using
BamHI and EcoRI or KpnI restriction sites, which were introduced by
PCR using the following primers: ARF 1 forward: 5
 
9
 
 CGC GGA TCC
CCA GCA ATG ACA GAG AGC GTG TG 3
 
9
 
, reverse: 5
 
9
 
 CCG GAA
TTC AAT CCC GGA GCT CGT CCT CGG C 3
 
9
 
; ARF 4 forward: 5
 
9
 
GCG GGA TCC CCA TGG GCC TCA CTA TCT CCT CC 3
 
9
 
, reverse:
5
 
9
 
 CGG GGT ACC AAC TAA TTT TGT TGT AAC AAG CCT 3
 
9
 
;
ARF 5 forward: 5
 
9
 
 CGC GGA TCC CCA GTA ATG ACC GGG AGC
GGG TC 3
 
9
 
, reverse: 5
 
9
 
 CCG GAA TTC AAT CCC GCA GCT CGT
CCT CCT G 3
 
9
 
; ARF 6 forward: 5
 
9
 
 CGC GGA TCC CCT GCG CCG
ACC GCG ACC GCA TC 3
 
9
 
, reverse: 5
 
9
 
 CCG GAA TTC AGT CCC
TCA TCT CCC GGT CAT T 3
 
9
 
. 
MC1061 cells were transformed with the plasmids and expression of
the GST fusion proteins was induced with 0.1 mM IPTG. The fusion pro-
teins were affinity purified on glutathione-Sepharose (Pharmacia LKB
Biotech., Piscataway, NJ), using the method of Smith and Johnson (1988),
and injected into rabbits using 0.5 mg in complete Freund’s adjuvant for
the first injection and 0.5 mg in incomplete Freund’s adjuvant for two sub-
sequent injections (Page and Robinson, 1995). Affinity purification of the
resulting antisera was carried out essentially as previously described (Page
and Robinson, 1995). Briefly, 10 ml of each serum was first adsorbed
against 1 mg of GST coupled to CNBr-activated Sepharose (Pharmacia
LKB Biotech.) and then affinity purified on 1 mg of its own fusion protein
coupled to CNBr-activated Sepharose. Bound antibodies were eluted with 
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0.2 M glycine, pH 2.3, containing 0.1% gelatine. To select for monospe-
cific antibodies, each of the affinity-purified sera was adsorbed at least
twice against a mixture of the other full-length ARF–GST fusion proteins
(1 mg each) coupled to CNBr-activated Sepharose.
To test the specificity of the antibodies, 50 
 
m
 
g of each full-length ARF–
GST fusion protein was digested with 500 ng activated Factor X according
to Smith and Johnson (1988) to generate GST-free ARFs. The digests
were subjected to SDS-PAGE on a 15% SDS gel, and Western blots were
probed with the various antisera.
 
Expression and Purification of Recombinant ARF1
 
Recombinant myristoylated wild-type and mutant ARF1 were prepared
from BL21 
 
Escherichia coli
 
 that had been transformed with plasmids en-
coding 
 
N
 
-myristoyl transferase and either wild-type ARF1, Q71L ARF1,
or T31N ARF1 (Dascher and Balch, 1994). The transformed cells were in-
duced with 0.3 mM IPTG in the presence of 50 
 
m
 
M myristate and grown at
27
 
8
 
C for 3 h (Franco et al., 1995). The cells were lysed, and the expressed
ARF1 was purified using DEAE-Sephacel and AcA54 Ultrogel columns
as described by Weiss et al. (1989). This particular strain of transformed
bacteria has been shown to myristoylate 10–60% of the protein (Ran-
dazzo et al., 1993).
 
Rat Liver Fractionation
 
Fractionation of rat liver membranes was carried out essentially as de-
scribed by Branch et al. (1987). 15 g of rat liver was homogenized in 40 ml
of cold 0.25 M sucrose, 10 mM TES, pH 7.4, 1 mM MgCl
 
2
 
 (STM), and a
postmitochondrial supernatant was prepared by centrifuging the homoge-
nate at 1500 
 
g
 
 for 10 min. 5-ml samples of this were loaded onto 34-ml lin-
ear gradients prepared from 0.25 M sucrose, 10 mM TES pH 7.4, 1 mM
EDTA, and 45% Nycodenz in 10 mM TES pH 7.4, 1 mM EDTA. The gra-
dients were centrifuged at 206,000 
 
g
 
 for 60 min in a vertical rotor (model
VTi50; Beckman Instruments, Fullerton, CA), and 1-ml fractions were
collected by upwards displacement.
 
Preparation of Cytosol
 
Pig brain cytosol was prepared in cytosol buffer (25 mM Hepes-KOH, pH
7.0, 125 mM potassium acetate, 2.5 mM magnesium acetate, 1 mg/ml glu-
cose, 1 mM DTT) as described by Seaman et al. (1993). The cytosol was
clarified before use by centrifuging at 350,000 
 
g
 
 for 15 min in a rotor
(model TL100.2; Beckman Instruments) and was used at a final protein
concentration of 
 
z
 
8 mg/ml.
For ARF depletion, 4 ml of cytosol was fractionated at 30 ml/h on a Su-
perose 6 column (45 
 
3
 
 1.6 cm) equilibrated in cytosol buffer containing
0.2 mM PMSF. Fractions containing ARFs were identified by Western
blotting, and the remaining ARF-depleted fractions pooled and concen-
trated to the original volume using a Centricon-10 concentrator (Amicon,
Beverly, MA). ARF immunoreactivity was undetectable in the ARF-
depleted fractions.
 
In Vitro Recruitment
 
Recruitment experiments were carried out both on enriched rat liver
membrane fractions and on permeabilized normal rat kidney (NRK) cells.
400-
 
m
 
l aliquots of the membrane fractions, prepared as above, were di-
luted threefold with STM and collected by pelleting at 90,000 
 
g
 
 for 15 min
in a rotor (model TL100.2; Beckman Instruments). Membrane pellets were
resuspended in 50 
 
m
 
l of cytosol containing 1 mM ATP, an ATP-regenerat-
ing system (5 mM creatine phosphate, 80 
 
m
 
g/ml creatine phosphokinase),
and 100 
 
m
 
M EGTA and incubated at 37
 
8
 
C for 10 min. GTP
 
g
 
S, when in-
cluded, was used at a concentration of 100 
 
m
 
M. After the incubation, the
membranes were diluted with 1 ml of cold STM and collected by centrifu-
gation as before. The pellets were resuspended in 50 
 
m
 
l of SDS-PAGE
sample buffer, and 10-
 
m
 
l aliquots were subjected to SDS-PAGE and
Western blotting. Blots were probed with the brain-specific rabbit anti–
 
a
 
-
adaptin antibody, A706-727 (Ball et al., 1995), or the species-specific
mouse anti–
 
g
 
-adaptin monoclonal antibody, mAb100/3 (Sigma Chemical
Co., Poole, UK) (Ahle et al., 1988) and rabbit anti–mouse IgG (Sigma
Chemical Co.), followed by 
 
125
 
I–protein A (Amersham Corp., Indianapo-
lis, IN). Quantification was carried out using a phosphorimager (FujiX
Bas2000 Bio-Imaging Analyzer; Fuji Photo Film Co., Tokyo, Japan). Each
experiment was carried out at least three times to ensure that the results
were reproducible.
In some experiments, recombinant ARF1, bacterial PLD, and/or neo-
mycin were added. Recombinant ARF1 was added to a final concentra-
tion of between 20 
 
m
 
g/ml and 200 
 
m
 
g/ml, depending on the experiment.
Endogenous ARF1 in our cytosol preparations was estimated to be 
 
z
 
10
 
m
 
g/ml by Western blotting. Bacterial PLD (type VII from 
 
Streptomyces
 
species) was obtained from Sigma Chemical Co. It had a specific activity
of 1,200 U/mg, 1 U being defined as the amount of enzyme required to lib-
erate 1 
 
m
 
mol of choline per hour at pH 5.6 at 30
 
8
 
C. It was added to a final
concentration of between 0.5 and 37.5 
 
m
 
g/ml, depending on the experi-
ment. As a comparison, in a recent study by Ktistakis et al. (1996), bacte-
rial PLD was added to a final concentration of 4 
 
m
 
g/ml, although the spe-
cific activity was measured differently (50 U/mg, 1 U being defined as the
amount of enzyme that will hydrolyze 1.0 
 
m
 
mol of phosphatidylcholine
per min at 37
 
8
 
C). Neomycin was also obtained from Sigma Chemical Co.
and was added at concentrations ranging from 0.03 to 3.0 mM.
Methods for recruitment onto permeabilized NRK cells have been pre-
viously described (Robinson and Kreis, 1992; Seaman et al., 1993). 
 
a
 
- and
 
g
 
-adaptins were labeled for immunofluorescence with A706-727 and
mAb100/3 followed by FITC anti–rabbit IgG or Texas red anti–mouse
IgG (Amersham Corp.), respectively. Each experiment was repeated at
least three times.
 
Assay for PLD Activity
 
PLD activity was determined essentially as described by Bi et al. (1997).
Briefly, NRK cells grown to 
 
z
 
90% confluency were labeled overnight
with 25 
 
m
 
Ci/ml [
 
3
 
H]palmitic acid (Amersham Corp.), and then cells from
two 9-cm-diam dishes were washed with cytosol buffer, frozen in liquid ni-
trogen and rapidly thawed, scraped from the dishes, and incubated as
eight aliquots, each with 50 
 
m
 
l cytosol containing 1% butanol for 20 min.
GTP
 
g
 
S and neomycin were added as indicated. Cellular lipids were then
extracted, and the organic phase was subjected to thin-layer chromatogra-
phy (TLC) as described by Bi et al. (1997). Radioactivity was quantified
using a phosphorimager, and the phosphatidyl butanol produced in each
tube was normalized using other radiolabeled lipids to control for variabil-
ity in recovery and/or loading. Another two dishes of cells were grown un-
der identical conditions but without the [
 
3
 
H]palmitic acid, permeabilized
as above, and used to assay AP-2 recruitment under the same conditions.
 
Electron Microscopy
 
For immunogold localization of newly recruited AP-2 adaptors, NRK
cells grown in 60-mm dishes were permeabilized by immersion into liquid
nitrogen before incubation with cytosol, as previously described (Seaman
et al., 1993). At the end of the incubation, the cells were washed gently
with cytosol buffer and then fixed for 1 h with 4% paraformaldehyde,
0.1% glutaraldehyde in 0.25 M Hepes, pH 7.2, before scraping, pelleting,
and embedding in 10% gelatine. For examination of rat liver membranes,
recruitment was carried out on gradient fractions as above, and the pellets
were fixed and embedded in 10% gelatine. Cryosections were prepared,
immunolabeled, and contrasted as described by Simpson et al. (1996).
Newly recruited AP-2 adaptor complexes were detected using the A706-
727 anti–
 
a
 
-adaptin antibody. The anti-lgp110 antibody was a kind gift
from Paul Luzio (University of Cambridge, Cambridge, UK) (Reaves et
al., 1996).
 
Results
 
Recruitment of AP-2 Adaptors onto Rat
Liver Membranes
 
Previous studies have shown that the recruitment of adap-
tor complexes onto membranes can be reconstituted in
vitro using permeabilized NRK cells as a source of target
membranes and pig brain cytosol as an exogenous source
of adaptors. After incubation at 37
 
8
 
C in the presence of an
ATP-regenerating system, newly recruited adaptors can
be detected by immunofluorescence using species- or tis-
sue-specific antibodies that do not recognize the endoge-
nous adaptors (Robinson and Kreis, 1992; Seaman et al.,
1993). We have adapted this system to allow a more quan-
titative assessment of adaptor recruitment, using enriched 
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Figure 1.
 
Recruitment of cytosolic proteins onto rat liver membranes. (
 
a
 
) To determine the specificity of the anti-ARF antibodies raised
in this study, samples of ARF–GST fusion proteins were digested with Factor X and the digests subjected to SDS-PAGE on 15% gels
and Western blotted. Identical panels were probed with affinity-purified and cross-adsorbed anti-ARF antisera as indicated. Non–cross-
adsorbed anti-ARF1 labels all four ARF isoforms, while after cross-adsorption each antibody is specific for its own isoform. ARF3,
which is 97% identical to ARF1, was not included in this study. (
 
b
 
) Membranes from a Nycodenz gradient were incubated with pig brain
cytosol in the presence or absence of GTP
 
g
 
S. The incubation mixture in this experiment and in all subsequent experiments also con-
tained ATP and an ATP-regenerating system. After the incubation, membranes were pelleted and assayed by Western blotting for the 
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rat liver fractions as the source of target membranes. To
investigate whether any of the ARFs cofractionate with
membranes that bind adaptors, we have raised antisera
against ARFs 1, 4, 5, and 6 and then cross-adsorbed them
with the other ARF isoforms. Fig. 1 
 
a
 
 shows Western blots
probed with the various ARF antisera and demonstrates
that each of the adsorbed antisera recognizes only its ap-
propriate ARF, while an antiserum raised against ARF1
and not adsorbed recognizes ARFs 1, 4, 5, and also 6 to a
lesser extent.
To generate target membranes for adaptor recruitment,
rat liver postmitochondrial supernatants (5 ml) were frac-
tionated on a 34-ml Nycodenz gradient, and 1-ml fractions
were incubated with pig brain cytosol in the presence of an
ATP-regenerating system, either with or without GTP
 
g
 
S.
The various ARF isoforms were detected by probing
Western blots with the antisera shown in Fig. 1 
 
a
 
, while
newly recruited adaptor complexes were detected with a
brain-specific anti–
 
a
 
-adaptin antibody (A706-727) (Ball et
al., 1995) for AP-2 adaptors and a species-specific anti–
 
g
 
-
adaptin antibody (mAb100/3) (Ahle et al., 1988) for AP-1
adaptors (Fig. 1 
 
b
 
).
In the absence of GTP
 
g
 
S, newly recruited AP-2 adap-
tors were found to bind to membranes that were broadly
distributed throughout the upper half of the gradient, with
a slight peak in fractions 15–18. ARF6 could also be de-
tected in the absence of GTP
 
g
 
S and was found to peak in
fractions 15–19. The other ARF isoforms, and newly re-
cruited AP-1 adaptors, were unable to be detected under
these conditions (data not shown). In the presence of
GTP
 
g
 
S, the binding of AP-2 adaptors was found to be en-
hanced and was shifted somewhat to less dense mem-
branes. This shift is consistent with GTP
 
g
 
S inducing the
recruitment of AP-2 onto a different (i.e., endosomal)
compartment (Seaman et al., 1993). GTP
 
g
 
S also facilitated
the binding of the other ARF isoforms and AP-1 adaptors
to membranes. The membranes that bound AP-1 and the
membranes that bound the various ARFs had similar frac-
tionation profiles, peaking between fractions 14 and 18 or
19. The nonadsorbed ARF1 antibody, which cross-reacts
with all of the known ARFs and possibly also with other as
yet unidentified ARFs, produced a strong signal that also
peaked between fractions 14 and 19 but which extended
into the lighter portion of the gradient. In contrast, the
membranes that bound AP-2 in the presence of GTP
 
g
 
S
had a different fractionation profile, with a broad peak be-
tween fractions 9 and 17. These results suggest either that
low levels of a conventional ARF may facilitate the
GTP
 
g
 
S-dependent recruitment of AP-2 onto these mem-
branes, or alternatively that a novel ARF could be in-
volved.
To confirm that the AP-2 detected in this assay was in
fact membrane associated, fractions were fixed after incu-
bation with pig brain cytosol and processed for immuno-
electron microscopy (Fig. 1 
 
c
 
), using the brain-specific
anti–
 
a
 
-adaptin antibody followed by 10-nm protein A
gold. Without GTP
 
g
 
S, low levels of newly recruited AP-2
were observed associated with small vesicles. In the pres-
ence of GTP
 
g
 
S, enhanced labeling was seen that tended to
be associated with larger membranous structures. These
structures often contained internal membranes and are
likely to correspond to the endosomal compartment to
which AP-2 is targeted in permeabilized cells (Seaman et
al., 1993), while the smaller vesicles labeled in the absence
of GTP
 
g
 
S are likely to be derived from the plasma mem-
brane.
 
Role of ARF1 in the Binding of AP-2 Adaptors
 
To determine whether low levels of a conventional ARF,
such as ARF1, might be involved in the binding of AP-2 to
endosomes, we generated ARF-depleted cytosol by gel fil-
tration and then added back defined components. Fig. 2
(
 
first three lanes
 
) shows an experiment in which the ARF-
depleted cytosol was mixed with low molecular weight,
ARF-containing fractions to generate reconstituted cyto-
sol and then added to membranes in the presence or ab-
sence of GTP
 
g
 
S. The addition of GTP
 
g
 
S increased the
 
various ARF isoforms, or for newly recruited AP-2 or AP-1 adaptor complexes using brain-specific anti–
 
a
 
- or species-specific anti–
 
g
 
-
adaptin antibodies, respectively. Significant amounts of both 
 
a
 
-adaptin and ARF6 are associated with membranes even in the absence of
GTP
 
g
 
S, although they show only partial overlap. In the presence of GTP
 
g
 
S, the binding of AP-2 is increased and the fractionation pro-
file shifted to less dense membranes. The other ARF isoforms and AP-1 are also recruited onto membranes and show similar fraction-
ation profiles to each other but not to AP-2. (
 
c
 
) Frozen thin sections were prepared from samples equivalent to 8–19 in 
 
b.
 
 The sections
were labeled with brain-specific anti–
 
a
 
-adaptin, followed by 10-nm protein A gold. In the absence of GTP
 
g
 
S, AP-2 is recruited onto
small vesicles, presumably derived from the plasma membrane, while in the presence of GTP
 
g
 
S, AP-2 is recruited onto larger structures
that often contain internal membranes, characteristic of endosomes. Bar, 200 nm.
Figure 2. Role of ARF1 in AP-2 recruitment. Aliquots of peak
fractions from a Nycodenz gradient were incubated with either
reconstituted cytosol or with high–molecular weight, ARF-
depleted fractions of cytosol that had been gel filtered. GTPgS
and recombinant myristoylated ARF1 were included as indi-
cated. Newly recruited AP-2 adaptors (a) and membrane-associ-
ated ARF1 were detected by Western blotting. When reconsti-
tuted cytosol was added, AP-2 recruitment onto the membranes
was enhanced by the addition of GTPgS. No such enhancement
was seen with the ARF-depleted cytosol, but it was restored by
the addition of recombinant myristoylated ARF1.The Journal of Cell Biology, Volume 138, 1997 1244
Figure 3. Effects of ARF1 mutants on adaptor recruitment. Aliquots of pooled peak fractions from a Nycodenz gradient were used as
acceptor membranes for the recruitment of (a) AP-2 (a) or (b) AP-1 (g). These membranes were incubated with cytosol containing ei-
ther GTPgS, Q71L ARF1, or T31N ARF1 and then subjected to SDS-PAGE and Western blotting. Q71L ARF1, but not T31N ARF1,
stimulates the recruitment of both types of adaptors even in the absence of GTPgS. (c–h) Permeabilized NRK cells were incubated with
either cytosol alone (c) or cytosol containing 100 mg/ml T31N ARF1 (d), GTPgS (e and f), or 100 mg/ml Q71L ARF1 (g and h), and
newly recruited AP-2 or AP-1 adaptors were detected using anti-a (c, d, e, and g) or anti-g (f and h) antibodies. Q71L ARF1 has a
GTPgS-like effect on both types of adaptors, indicating that in both cases the GTPgS is acting via ARF. Bar, 10 mm.West et al. Differential Regulation of AP-1 and AP-2 Recruitment 1245
binding of AP-2 adaptors to the membranes and also
caused trace amounts of ARF1 to bind. In contrast, mem-
branes incubated with ARF-depleted cytosol alone
showed only a basal level of AP-2 recruitment, which was
not increased with GTPgS (Fig. 2, fourth and fifth lanes).
To determine whether ARF1 could substitute for the ARF-
containing fractions, recombinant myristoylated ARF1
was included with ARF-depleted cytosol. The last four
lanes of Fig. 2 show that the recombinant ARF1 protein
fully restored the GTPgS-enhanced binding of AP-2 adap-
tors and was itself recruited onto the membrane as well, al-
though at lower levels.
Because GTPgS is likely to have multiple effects, we
also tested whether the Q71L mutant of ARF1, which hy-
drolyzes GTP poorly (Tanigawa et al., 1993), could mimic
the effect of GTPgS on AP-2 recruitment. For these ex-
periments, unfractionated cytosol was used since the Q71L
mutant is expected to have a dominant effect. Fig. 3 a
shows that 50 mg/ml of the mutant ARF1 strongly stimu-
lated the binding of AP-2 to membranes, giving levels of
recruitment approaching that seen with GTPgS. Higher
concentrations (100 and 200 mg/ml) of Q71L ARF1 in-
creased AP-2 binding slightly further. Equivalent amounts
of the dominant negative ARF1 mutant, T31N (Dascher
and Balch, 1994), did not enhance AP-2 binding over lev-
els seen without GTPgS. Q71L ARF1 also promoted the
membrane recruitment of g-adaptin (Fig. 3 b), as expected
since ARF1 has been demonstrated to have a role in AP-1
adaptor recruitment to the TGN (Stamnes and Rothman,
1993; Traub et al., 1993). However, the effect of the mu-
tant ARF1 on AP-1 was more moderate than on AP-2
adaptors in that even 200 mg/ml Q71L ARF1 did not
stimulate AP-1 recruitment to quite the levels seen with
GTPgS.
To confirm that Q71L ARF1 causes AP-2 adaptors to
bind to the perinuclear endosomal compartment, a recruit-
ment experiment was carried out using permeabilized
NRK cells, and the cells were labeled for immunofluores-
cence using the tissue-specific a-adaptin antibody. After
incubating the cells with cytosol alone, a punctate plasma
membrane pattern was seen (Fig. 3 c). This same type of
labeling was seen when T31N ARF1 was included (Fig. 3
d). Only faint AP-1 recruitment was detected under either
of these conditions (not shown). When GTPgS was in-
cluded in the incubation, intense perinuclear labeling of
a-adaptin, characteristic of endosomal targeting, was ob-
served (Fig. 3 e). A very similar pattern was seen when
Q71L ARF1 was included instead of GTPgS (Fig. 3 g).
With either GTPgS or Q71L ARF1, perinuclear labeling
of newly recruited g-adaptin was also detected (Fig. 3, f
and h), consistent with its TGN localization (Robinson
and Kreis, 1992). However, this pattern was distinct from
the perinuclear labeling seen for AP-2 adaptors (see Sea-
man et al., 1993).
Thus, these data indicate that ARF1 can mediate the
binding of AP-2 adaptors to the endosomal compartment,
even though there is relatively little ARF1 associated with
this compartment.
Phospholipase D Can Stimulate AP-2 Recruitment
How is ARF1 acting to promote the recruitment of AP-2
adaptors onto endosomes? The relatively low levels of
ARF1 associated with the endosomal compartment sug-
gest that it may be acting catalytically. One possibility is
that it may be acting via PLD since previous reports have
shown that ARF is an effective activator of this enzyme
(Brown et al., 1993; Cockcroft et al., 1994). PLD hydro-
lyzes phosphatidylcholine to phosphatidic acid (PA), which
along with PIP2 has been proposed to contribute to
coatomer binding to membranes (Ktistakis et al., 1996). If
ARF1 acts in AP-2 recruitment via activation of PLD,
then the addition of exogenous active PLD should bypass
the requirement for activated ARF to give enhanced re-
cruitment.
Fig. 4 a shows an experiment assessing the recruitment
of cytosolic AP-2 adaptors onto rat liver membranes in the
presence of varying amounts of bacterial PLD. Although
EGTA is normally added to the incubation mixture, most
of these incubations were carried out in the absence of
EGTA since bacterial PLD is reported to require Ca21 for
maximum activity (Imamura and Horiuti, 1979). Under
these conditions, the membrane association of AP-2 adap-
tors in both the absence and the presence of GTPgS is re-
duced, although a GTPgS enhancement of recruitment is
still observed (Fig. 4 a, first five lanes). When the effect of
adding exogenous PLD was tested, we found that bacterial
PLD can effectively substitute for GTPgS in promoting
AP-2 recruitment. At low concentrations of PLD (e.g., 0.1
mg/ml), the addition of 1 mM EGTA was found to inhibit
PLD-induced recruitment by z70%, but at concentrations
of 2.5 mg/ml or above, 1 mM EGTA only inhibited by
z40% (data not shown). In addition, because EGTA itself
promotes AP-2 recruitment, at high concentrations of
PLD similar amounts of AP-2 were found to be recruited
onto the membrane in the absence and in the presence of
EGTA (Fig. 4 a, last lane).
Perhaps surprisingly, since its membrane association is
believed to be ARF1 mediated, the recruitment of AP-1
adaptors was not appreciably enhanced by PLD, even at
the highest concentrations used (Fig. 4 b). Thus, although
GTPgS and Q71L ARF1 stimulate both AP-1 and AP-2
recruitment, the finding that only AP-2 recruitment is
stimulated by PLD suggests that the mechanisms of
ARF1-dependent AP-1 and AP-2 recruitment may differ.
The effect of PLD was also examined using permeabil-
ized NRK cells. For these experiments, 12.5 mg/ml PLD
plus 100 mM EGTA were used to avoid any Ca21-induced
mistargeting (see Seaman et al., 1993). As previously
shown, in the absence of GTPgS or PLD, AP-2 adaptors
were recruited onto the plasma membrane (Fig. 4 c) and
AP-1 adaptors showed a faint perinuclear localization
(Fig. 4 d), while in the presence of GTPgS, AP-1 recruit-
ment was increased (Fig. 4 f) and AP-2 adaptors bound to
a perinuclear compartment (Fig. 4 e). When bacterial PLD
was included in the incubation mixture, the enhanced AP-2
recruitment detected biochemically on rat liver mem-
branes (Fig. 4 a) was seen to correlate with perinuclear
staining (Fig. 4 g), morphologically similar to that induced
by GTPgS (Fig. 4 e). Some punctate plasma membrane
staining was also observed, but this did not seem to be in-
creased in the presence of PLD. Double labeling of the
same cells for g-adaptin confirmed the lack of effect of
PLD on AP-1 adaptor recruitment (Fig. 4 h).The Journal of Cell Biology, Volume 138, 1997 1246
Figure 4. Effect of exogenous PLD on adaptor recruitment. (a and b) Membrane pools (see Fig. 3) were incubated with cytosol contain-
ing bacterial PLD, EGTA (100 mM), and GTPgS in combinations as indicated, and either a (a) or g (b) recruitment was detected by
Western blotting. PLD mimics the GTPgS effect on AP-2 recruitment, but not on AP-1 recruitment. (c–h) Recruitment onto permeabi-
lized NRK cells was carried out with cytosol alone (c and d), with GTPgS (e and f) or with 12.5 mg/ml PLD (g and h). The same cells
were double labeled for immunofluorescence using either the anti-a (c, e, and g) or anti-g (d, f, and h) antibodies. PLD only has a
GTPgS-like effect on the AP-2 adaptors. Bar, 10 mm.West et al. Differential Regulation of AP-1 and AP-2 Recruitment 1247
Neomycin Inhibits Both Endosomal and Plasma 
Membrane AP-2 Recruitment
The effect of exogenous bacterial PLD on AP-2 recruit-
ment suggests that GTPgS exerts its effect through the
cell’s endogenous PLD. If this is the case, then inhibitors
of the endogenous PLD activity would be expected to pre-
vent or reduce the GTPgS-stimulated AP-2 recruitment.
Although multiple PLD activities have been described, it
has been reported that the mammalian ARF-dependent
PLD requires PIP2 as a cofactor for optimum activity
(Hammond et al., 1995). Thus, we investigated the effects
of including the drug neomycin, a high-affinity ligand of
PIP2 that inhibits membrane-bound PLD activity (Lisco-
vitch et al., 1994), in the incubation.
When 1 mM neomycin was added, the amount of newly
recruited AP-2 was significantly reduced both in the ab-
sence and in the presence of GTPgS (Fig. 5 a). 0.1 mM
neomycin gave a lesser but still detectable inhibition. We
also assessed the effect of neomycin on AP-2 recruitment
induced by the dominant active Q71L ARF1 since it is for-
mally possible that ARF and PLD may independently lead
to the binding of AP-2 adaptors to endosomes. However,
neomycin had the same effect on Q71L-induced recruit-
ment as on GTPgS-induced recruitment, indicating that
the activities of ARF1 and PLD are in fact coupled (data
not shown). In contrast, the recruitment of AP-1 adaptors
was unaffected by neomycin, even at 1 mM (Fig. 5 b).
These observations were confirmed by immunofluores-
cence labeling of permeabilized cells after adaptor recruit-
ment (Fig. 6). The normal punctate plasma membrane re-
cruitment of AP-2 adaptors seen in the absence of GTPgS
was much reduced by the presence of 1 mM neomycin in
the incubation (Fig. 6, compare a and c). In the same cells,
neomycin did not appear to affect the basal levels of AP-1
(Fig. 6, b and d). Similarly, the GTPgS-induced perinu-
clear targeting of AP-2 adaptors was also strongly inhib-
ited (Fig. 6, compare e and g), while AP-1 recruitment in
the same cells was apparently unaffected by treatment
with neomycin (Fig. 6, f and h). Thus, these experiments
confirm a role for PLD activity in the binding of AP-2 to
endosomal membranes in vitro, and in addition they impli-
cate PLD in the normal recruitment of AP-2 adaptors
onto the plasma membrane.
To compare the effect of neomycin on AP-2 recruitment
with its effect on PLD activity, NRK cells were grown
overnight with [3H]palmitic acid to label membrane lipids.
They were then permeabilized and incubated for 20 min
with increasing concentrations of neomycin plus 1% bu-
tanol so that PLD activity could be measured by assaying
for the production of phosphatidyl butanol. At the end of
the incubation, lipids were extracted and analyzed by
TLC. A similar experiment was carried out on unlabeled
NRK cells to assess the effect of the same concentrations
of neomycin on AP-2 recruitment. Fig. 7 shows the results
of the two experiments.
Because whole cells were used, the effect of GTPgS on
AP-2 recruitment was less pronounced than on membrane
fractions, although recruitment could be inhibited by incu-
bating the cells at 48C (Fig. 7 a). When neomycin was
added to the cells, there was a steady decline in recruit-
ment with increasing concentrations of the drug, and at 3
mM neomycin, AP-2 binding was essentially undetectable.
Increasing concentrations of neomycin also inhibited PLD
activity, but the effect was less pronounced, and even at 3
mM the production of phosphatidyl butanol in GTPgS-
treated cells was only diminished by z40% (Fig. 7 b).
However, it is worth noting that the addition of GTPgS
only stimulated PLD activity by z30% over the level
found in the absence of GTPgS. This result suggests that
much of the PLD activity is ARF independent and might
not be susceptible to neomycin. In addition, it is possible
that PIP2 may play a direct role in AP-2 recruitment, as
well as an indirect role via PLD (see Discussion).
Characterization of AP-2–binding Membranes
The immunofluorescence results presented so far demon-
strate that GTPgS, Q71L ARF1, and PLD all cause AP-2
adaptors to bind to a perinuclear compartment. However,
there are many organelles concentrated in the perinuclear
region of the cell. To confirm that all three treatments
cause the adaptors to bind to the same compartment, we
investigated the localization of the newly recruited AP-2
adaptors by subcellular fractionation and by immunogold
electron microscopy.
Rat liver membrane pools from Nycodenz gradients
were incubated with cytosol in the presence of GTPgS,
Q71L ARF1, or PLD, and the recruitment of adaptor
complexes onto each pool was assessed by Western blot-
ting and quantified using a phosphorimager. Membranes
binding AP-1 and AP-2 adaptors in the presence of
GTPgS had distinct fractionation profiles, as shown previ-
ously (Fig. 8 a; see also Fig. 1 b). AP-2 adaptors recruited
Figure 5. Effect of neomycin on the recruitment of adaptors onto
rat liver membranes. Rat liver membrane pools (see Fig. 3) were
incubated with cytosol in the absence or presence of GTPgS and
varying concentrations of neomycin. The effect of neomycin on
AP-1 and AP-2 recruitment was assessed by Western blotting of
the membrane samples using anti-a (a) or anti-g (b) antibodies.
Neomycin, which indirectly inhibits PLD activity, decreases the
amount of AP-2 recruitment both in the absence and in the pres-
ence of GTPgS but has no appreciable effect on AP-1 recruit-
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Figure 6. Effect of neomycin on adaptor recruitment in permeabilized cells. Permeabilized NRK cells were allowed to recruit adaptors
from cytosol in the absence (a–d) or presence (e–h) of GTPgS. Neomycin (1 mM) was included in c, d, g, and h. For each of the condi-
tions, the cells were double labeled for immunofluorescence using anti-a (a, c, e, and g) or anti-g (b, d, f, and h) antibodies. Photographs
in the presence and in the absence of neomycin were taken and printed under identical conditions. Neomycin inhibits the recruitment of
AP-2 adaptors both onto the plasma membrane in the absence of GTPgS and onto the endosomal compartment in the presence of
GTPgS, without showing any effect on AP-1 recruitment. Bar, 10 mm.West et al. Differential Regulation of AP-1 and AP-2 Recruitment 1249
in the presence of Q71L ARF1 gave a very similar profile
to that seen with GTPgS (Fig. 8 a). In a separate experi-
ment, fractions were incubated with cytosol containing ei-
ther GTPgS or exogenous PLD and then assayed for
newly recruited AP-2, and again the profiles were found to
be similar (Fig. 8 b).
To investigate the localization of the AP-2 adaptors at
an ultrastructural level, we carried out a recruitment ex-
periment using permeabilized NRK cells incubated with
cytosol in the presence of GTPgS, Q71L ARF1, or PLD
and then prepared frozen thin sections of the cells for im-
munogold electron microscopy. When the recruitment was
carried out in the presence of GTPgS, the AP-2 adaptors
(labeled with large gold particles) were detected on endo-
some-like structures, often with internal membranes, and
on smaller tubulovesicular elements, often in close prox-
imity to the Golgi stack (Fig. 9, a and b). A proportion of
these structures were also positive for lgp110, a marker for
late endosomes and lysosomes (small gold particles) (Reaves
et al., 1996). These data are consistent with the previous
identification of this compartment as a late endosome
(Seaman et al., 1993). When either Q71L ARF1 or PLD
were included in the cytosol, AP-2 adaptors were recruited
to structures of a similar appearance to those observed
with GTPgS, including multivesicular bodies that some-
times colabeled for lgp110 and smaller tubulovesicular
profiles (Fig. 9, c–f). We could detect no significant mor-
phological difference in the membrane structures onto
which AP-2 adaptors were recruited under these three
conditions, indicating that GTPgS, Q71L ARF1, and PLD
all activate the same pathway.
Discussion
Previous studies have shown that the recruitment of both
AP-1 and AP-2 adaptors in vitro is affected by GTPgS. In
the case of AP-1 adaptors, GTPgS stimulates their recruit-
ment onto the TGN, the membrane with which they are
normally associated, and this event has been shown to be
mediated by ARF1 (Robinson and Kreis, 1992; Stamnes
and Rothman, 1993; Traub et al., 1993; Seaman et al.,
1996). In contrast, GTPgS causes AP-2 adaptors to be re-
cruited onto an endosomal compartment, even though
Figure 7. Comparison of the effects of neomycin on AP-2 recruit-
ment and on PLD activity. (a) Permeabilized NRK cells were al-
lowed to recruit adaptors from cytosol either without GTPgS,
with GTPgS at 48C, or with GTPgS plus increasing concentra-
tions of neomycin and then assayed by Western blotting and
phosphorimager quantification for AP-2 recruitment. The rela-
tively weak effect of GTPgS is due to the use of whole cells rather
than membrane fractions. Neomycin inhibits AP-2 recruitment in
a dose-dependent manner, with essentially complete inhibition at
3 mM. (b) NRK cells were labeled overnight with [3H]palmitic
acid, permeabilized, and then incubated with cytosol containing
1% butanol either without GTPgS or with GTPgS plus increasing
concentrations of neomycin. Lipids were extracted and subjected
to TLC, and PLD activity was assayed by quantifying the produc-
tion of phosphatidyl butanol. In one sample, the butanol was
omitted as a control. PLD activity is stimulated z30% by the ad-
dition of GTPgS and inhibited by neomycin, although even at 3
mM it is only inhibited z40%. This probably reflects the exist-
ence of multiple types of PLD in the cell, not all of which can be
inhibited by neomycin, and may also indicate that neomycin has a
direct effect on AP-2 recruitment, as well as an indirect effect by
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they are normally associated with the plasma membrane
(Seaman et al., 1993). Excess Ca21 was found to have a
similar effect (Seaman et al., 1993), and a recent study re-
ported that AP-2 adaptors can also bind to lysosomes in
vitro, although in this case the recruitment was carried out
under essentially physiological conditions, so it is not clear
why the adaptors bound to this compartment (Traub et al.,
1996). In addition, in living cells certain cationic am-
phiphilic drugs such as chlorpromazine cause AP-2 adap-
tors to bind to late endosomes and/or lysosomes (Wang et
al., 1993). Taken together, these studies indicate that AP-2
docking sites are present on membranes of the endolysoso-
mal system as well as the plasma membrane and that a
number of stimuli can switch them on. Whether the sites
on these membranes are normally completely inactive,
perhaps acting as a storage pool that can be mobilized to
the plasma membrane, or whether there is a very low level
of recruitment onto endosomes and lysosomes to facilitate
a particular trafficking pathway, is still not known.
In this study, we began by focusing on the effect of
GTPgS on AP-2 adaptors. We found that when ARFs and
other low molecular weight GTP-binding proteins were
removed from cytosol by gel filtration, the GTPgS effect
was lost but could be restored by the addition of recombi-
nant ARF1, indicating that ARF1 is the target of the
GTPgS. Further evidence for a role for ARF1 came from
our finding that the constitutively active ARF1 mutant,
Q71L ARF1, can substitute for GTPgS. Whether other
ARFs are equally effective at driving AP-2 onto endo-
somes is still not known. The endosomal membranes that
recruit AP-2 adaptors have relatively little ARF1 or any of
the other ARFs associated with them, suggesting that
ARF is acting catalytically rather than stoichiometrically.
Studies from other labs have shown that ARF activates
PLD (Brown et al., 1993; Cockcroft et al., 1994), and PLD
has been implicated in the recruitment of coatomer onto
Golgi membranes (Ktistakis et al., 1996). Similarly, we
found that exogenous PLD causes AP-2 adaptors to bind
to endosomes, indicating that ARF1 promotes recruitment
onto endosomes by activating endogenous PLD. Interest-
ingly, two other treatments that cause AP-2 to bind to en-
dosomes, elevated Ca21 levels and cationic amphiphilic
drugs, have also been reported to activate PLD (Brown et
al., 1995; Liscovitch et al., 1994; Siddiqi et al., 1995). In
contrast, exogenous PLD has no apparent effect on AP-1
adaptors, even though both GTPgS and Q71L ARF1
greatly stimulate the recruitment of AP-1 adaptors onto
the TGN.
Further evidence for the involvement of PLD in AP-2
recruitment comes from our studies on the effect of neo-
mycin. Neomycin inhibits PLD indirectly by binding to
PIP2, a cofactor for optimum enzyme activity (Hammond
et al., 1995). In our in vitro system, it inhibits not only the
recruitment of AP-2 onto endosomes but also the recruit-
ment of AP-2 onto the plasma membrane, without affect-
ing the recruitment of AP-1 onto the TGN. These observa-
tions suggest that under physiological conditions, endogenous
PLD associated with the plasma membrane may play a
Figure 8. Fractionation of
membranes binding adaptors
under various conditions.
Pools of pairs of membrane
fractions from Nycodenz gra-
dients were incubated with
cytosol in the presence of
GTPgS or 100 mg/ml Q71L
ARF (a) or in a separate ex-
periment in the presence of
GTPgS or 12.5 mg/ml PLD
(b). Newly recruited AP-2 or
AP-1 adaptors were detected
on Western blots using anti–a-
or anti–g-adaptin antibodies,
respectively. The signal in
each sample was quantified
using a phosphorimager. As
also shown in Fig. 1 b, a- and
g-adaptin–binding membranes
have  distinct fractionation
profiles. However, the profile
of the a-adaptin–binding
membranes is similar
whether GTPgS, Q71L ARF1,
or PLD is added.
Figure 9. Immunogold EM labeling of newly recruited AP-2 adaptors. Frozen thin sections were prepared of permeabilized NRK cells
that had been allowed to recruit proteins from cytosol in the presence of either GTPgS (a and b), Q71L ARF1 (100 mg/ml) (c and d), or
PLD (12.5 mg/ml) (e and f). The sections were labeled with antibodies against newly recruited a-adaptin (15-nm gold) and lgp110 (8-nm
gold). The arrows show membranes that are positive for both antigens, the large arrowheads show membranes that are positive for
a-adaptin only, and the small arrowheads show membranes that are positive for lgp110 only. The same types of membranes are labeled
under all three conditions. Bar, 200 nm.West et al. Differential Regulation of AP-1 and AP-2 Recruitment 1251The Journal of Cell Biology, Volume 138, 1997 1252
role in the recruitment of AP-2 adaptors. However, it is
difficult to dissociate the effects of PIP2 and PLD because
once the PLD is activated, it generates PA from phos-
phatidylcholine, and the PA can in turn activate phos-
phatidylinositol 4-P 5 kinase to generate more PIP2 (Jen-
kins et al., 1994). Thus, either one or both of these lipids
may be involved in AP-2 recruitment.
There are several observations that suggest that PIP2
may be at least as important as PA. First, AP-2 adaptors
have been shown to bind with high affinity to inositol
phosphates and inositol phospholipids (Beck and Keen,
1991; Gaidarov et al., 1996). Second, AP-2 adaptors re-
quire ATP in order to be recruited onto membranes (Sea-
man et al., 1993; Traub et al., 1996), and one possible role
for the ATP may be in the production of PIP2. Third, neo-
mycin has a stronger inhibitory effect on AP-2 recruitment
than on PLD activity, and although this result may be due
at least in part to interference from other types of PLD
that do not require PIP2, it also suggests that PIP2 may
play a more direct role in AP-2 recruitment. Fourth, we
have found that neomycin inhibits the recruitment of AP-2
adaptors onto endosomes not only in cells that have been
treated with GTPgS or Q71L ARF1, both of which pre-
sumably work by stimulating the cell’s endogenous PLD,
but also in cells that have been treated with exogenous PLD
from bacteria (data not shown). Since it is unlikely that
bacterial PLD requires PIP2 as a cofactor, this result also
indicates that PIP2 plays a direct role in AP-2 recruitment.
It may also be significant that AP-2 adaptors bind unusu-
ally tightly to hydroxylapatite (i.e., calcium phosphate)
(Pearse and Robinson, 1984), suggesting that AP-2 adap-
tors may have an affinity for phosphate groups in general.
Fig. 10 depicts a model for the recruitment of AP-2 adap-
tors onto the endosomal compartment. This model is based
on one proposed by Traub and Kornfeld for AP-1 recruit-
ment (Traub et al., 1993), and some of its aspects can be
adapted to describe other coating events as well. ARFs are
recruited from the cytosol through interaction with a
BFA-sensitive nucleotide exchange factor (Donaldson et
al., 1992; Helms and Rothman, 1992; Randazzo et al., 1993;
Peyroche et al., 1996), which catalyzes the exchange of
bound GDP for GTP. This leads to the exposure of the
myristoyl group on ARF, facilitating its association with
the membrane. The active ARF1, in conjunction with PIP2,
stimulates an endogenous PLD resulting in a local in-
crease in PA. PA then stimulates phosphatidylinositol 4-P
5 kinase to produce PIP2, which in turn further stimulates
PLD to generate more PA and in turn more PIP2. Such
positive feedback could rapidly lead to a local increase in
these acidic phospholipids. It seems unlikely that AP-2
binding is mediated by acidic phospholipids alone since
AP-2 is only recruited onto a specific subset of mem-
branes. Thus, we favor the hypothesis that there is an
AP-2–specific docking protein or protein complex, local-
ized both on the plasma membrane and on endosomes and
lysosomes, which is responsible for the initial binding of
AP-2 to the membrane. This docking site may act only
transiently, after which AP-2 may become more stably as-
sociated with the membrane through interactions with
acidic phospholipids, and possibly also through interac-
tions with the cytoplasmic domains of membrane proteins
that carry internalization signals.
According to this model, all of the proteins leading to
coat binding, i.e., ARF, PLD, and the putative docking
protein, could act catalytically and would not necessarily
be found to any great extent in the resulting coated pits or
vesicles. Indeed, there is no evidence for stoichiometric
quantities of any of the known ARFs, or of any other pro-
teins, in purified clathrin-coated vesicles. This model also
suggests that there may not necessarily be a direct interac-
Figure 10. Schematic model for the recruitment of AP-2 adaptors onto endosomal membranes. This model is based on the model of
Traub and Kornfeld for AP-1 adaptor recruitment (Traub et al., 1993), but with several important modifications. We propose that
ARF1 does not bind directly to the putative docking protein, but instead activates PLD, either directly or indirectly. Activated PLD, in
the presence of PIP2, may lead to rapid local changes in the concentrations of negatively charged phospholipids such as PA and PIP2.
These negatively charged phospholipids, together with the putative docking protein, would constitute an AP-2 binding site.West et al. Differential Regulation of AP-1 and AP-2 Recruitment 1253
tion between ARF and the docking protein, in contrast to
the model proposed by Traub and Kornfeld for AP-1 re-
cruitment (Traub et al., 1993).
In some respects, this model is similar to models pro-
posed for proteins such as rabs and ARFs, which use lipid
modifications to associate with membranes. The lipids do
not actually direct such proteins to a particular membrane
since proteins with the same lipid modification may associ-
ate with different membranes. Instead, it has been pro-
posed that such proteins initially interact with a specific
docking site (which in the case of ARF may also be its nu-
cleotide exchange factor), which causes a conformational
change so that the lipid becomes inserted into the mem-
brane bilayer (Donaldson and Klausner, 1994; Pfeffer,
1994). Similarly, AP-2 adaptors may interact with certain
lipid head groups after their initial binding to a specific
docking site. If the lipid head groups are rapidly turning
over, as is the case for both PA and PIP2, this would sug-
gest a means for releasing the adaptors once the coated
vesicle had formed (De Camilli et al., 1996). Possibly such
lipids are normally generated on the plasma membrane
rather than on endosomes, but addition of reagents such as
GTPgS, constitutively activated ARF1, Ca21, cationic am-
phiphyllic drugs, or exogenous PLD may cause unusually
high levels of these lipids to be generated on endosomes
and/or lysosomes. Whether the production of such lipids at
the plasma membrane depends upon an ARF or another
small GTP-binding protein is still not known, although
ARF6 is a potential candidate. ARF6, like the other
ARFs, has been shown to stimulate PLD (Brown et al.,
1995), but it differs from the other ARFs in that its
membrane association is unaffected by GTPgS or BFA.
Overexpressed ARF6 has been localized to the plasma
membrane and endosomes, and constitutively active or
constitutively inactive forms of ARF6 cause cells to accu-
mulate plasma membrane or endosomal membranes, re-
spectively, consistent with a role in endocytosis (Dsouza-
Schorey et al., 1995; Peters et al., 1995; Cavenagh et al.,
1996).
How well can this model be extrapolated to account for
other membrane coating events? It seems likely that the
recruitment of AP-2 adaptors onto the plasma membrane
also requires the activation of PLD and the generation of
acidic phospholipids, even though a conventional ARF is
probably not involved. Other coats that require ARF for
membrane binding, such as AP-1 adaptors and coatomer,
might be expected to use the same mechanism as that
shown in Fig. 10. Indeed, there is evidence that PLD medi-
ates coatomer binding to Golgi membranes (Ktistakis et
al., 1996), and coatomer has also been shown to interact
with inositol phosphates (Fleischer et al., 1994). In addi-
tion, membrane recruitment of the AP-3 adaptor-related
complex, which is BFA sensitive and therefore likely to re-
quire an ARF (Simpson et al., 1996), was significantly en-
hanced in the presence of exogenous PLD (data not
shown). Like AP-2, AP-3 requires ATP for its recruitment
in vitro (Simpson et al., 1996) and binds tightly to hydroxyl-
apatite (Simpson, F., and M.S. Robinson, unpublished ob-
servations). However, from the data presented here for
AP-1 adaptors, it is clear that the model may not always be
entirely applicable and that there may be variations on the
general mechanism. For example, although there is much
evidence to indicate that ARF1 mediates AP-1 binding to
membranes (Seaman et al., 1996; Stamnes and Rothman,
1993; Traub et al., 1993), we found that neither exogenous
PLD nor neomycin had any effect on AP-1. In addition,
AP-1 recruitment does not require ATP (Simpson et al.,
1996), indicating that PIP2 is not involved, it does not bind
particularly well to hydroxylapatite (Pearse and Robinson,
1984), and there is no evidence that it binds inositol phos-
phates or inositol phospholipids.
Thus, it seems clear that different binding mechanisms
have evolved for different coats. One common theme may
be that all coats make use of a small GTP-binding protein,
although the role of such a protein in the recruitment of
AP-2 onto the plasma membrane is still open to question.
However, the same GTP-binding protein may regulate dif-
ferent coats in different ways. Thus, although ARF1 may
promote the binding of AP-2 adaptors and coatomer by
activating PLD, it must use some other mechanism to pro-
mote the binding of AP-1 adaptors. A number of activities
have been attributed to ARF, and a number of interac-
tions with both proteins and phospholipids have been re-
ported (Bowman and Kahn, 1995; Kanoh et al., 1997). As
coat proteins and small GTP-binding proteins coevolved,
it seems likely that different coats became specialized to
make use of different regulatory mechanisms, while still
retaining a general requirement for ARF or an ARF-
related protein.
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